PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
75.78%
Some net income increase while MCHP is negative at -50.39%. John Neff would see a short-term edge over the struggling competitor.
No Data
No Data available this quarter, please select a different quarter.
466.67%
Some yoy growth while MCHP is negative at -72.35%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-221.88%
Negative yoy SBC while MCHP is 5.04%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
110.78%
Slight usage while MCHP is negative at -258.55%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
111.92%
AR growth while MCHP is negative at -112.76%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
215.63%
Inventory growth well above MCHP's 28.39%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
3.85%
A yoy AP increase while MCHP is negative at -33.52%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
17.28%
Some yoy usage while MCHP is negative at -388.87%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-48.98%
Both negative yoy, with MCHP at -6.12%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
78.07%
Some CFO growth while MCHP is negative at -63.85%. John Neff would note a short-term liquidity lead over the competitor.
-2.74%
Negative yoy CapEx while MCHP is 75.69%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-257.59%
Negative yoy purchasing while MCHP stands at 13.58%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-78.12%
Both yoy lines are negative, with MCHP at -22.54%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
-548.91%
Both yoy lines negative, with MCHP at -1.52%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
13.04%
Debt repayment growth of 13.04% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-7.35%
Negative yoy issuance while MCHP is 99.36%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-100.00%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.